Variant report
Variant | nsv613607 |
---|---|
Chromosome Location | chr9:12379547-12421929 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:116381055..116381867-chr9:12405688..12406208,2 | Hela-S3 | cervix: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs563358611 | chr9:12389811-12389812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs114465170 | chr9:12389816-12389817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs549093267 | chr9:12389824-12389825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs559504684 | chr9:12389881-12389882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs529237800 | chr9:12389887-12389888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs147819433 | chr9:12389902-12389903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs76658230 | chr9:12389908-12389909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189637996 | chr9:12389941-12389942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567315696 | chr9:12389945-12389946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537351821 | chr9:12389961-12389962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs550513656 | chr9:12389971-12389972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs567300490 | chr9:12389973-12389974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs536339767 | chr9:12389981-12389982 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553146926 | chr9:12389994-12389995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182658641 | chr9:12390027-12390028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs186987449 | chr9:12390036-12390037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs193203510 | chr9:12390062-12390063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs141010665 | chr9:12390068-12390069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs536356459 | chr9:12390081-12390082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs151213128 | chr9:12390135-12390136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs183442413 | chr9:12390139-12390140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs369659580 | chr9:12390141-12390142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs563319778 | chr9:12390143-12390144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs369199867 | chr9:12390148-12390149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs201512703 | chr9:12390152-12390153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs573730737 | chr9:12390163-12390164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs371647809 | chr9:12390183-12390184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs561153759 | chr9:12390219-12390220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs542702888 | chr9:12390222-12390223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs113100240 | chr9:12390226-12390227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs12342692 | chr9:12390266-12390267 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs528577564 | chr9:12390274-12390275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs188499567 | chr9:12390279-12390280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs193115704 | chr9:12390283-12390284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs150219208 | chr9:12390284-12390285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs184799627 | chr9:12390299-12390300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs367601464 | chr9:12390332-12390333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs10960654 | chr9:12390370-12390371 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs10809766 | chr9:12390462-12390463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs369609736 | chr9:12390474-12390475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs558690275 | chr9:12390491-12390492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs568985015 | chr9:12390492-12390493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs188390897 | chr9:12390512-12390513 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs191360748 | chr9:12390521-12390522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs573694056 | chr9:12390573-12390574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs575338102 | chr9:12390579-12390580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs578198770 | chr9:12390601-12390602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs114170422 | chr9:12390659-12390660 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs537411265 | chr9:12390670-12390671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs552955723 | chr9:12390671-12390672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chordoma | 21215367 | CNVD |
Renal cell carcinoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:12389800-12391000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr9:12390600-12390800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr9:12391000-12392000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr9:12391000-12394000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr9:12392000-12393000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr9:12392400-12395000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr9:12394000-12394600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr9:12394000-12395000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr9:12400800-12401800 | Enhancers | Fetal Kidney | kidney |
10 | chr9:12402400-12403000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr9:12404000-12404200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr9:12414000-12415600 | Enhancers | Fetal Kidney | kidney |
13 | chr9:12414200-12414600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
14 | chr9:12414400-12415600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr9:12414600-12414800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr9:12414800-12416200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
17 | chr9:12415000-12415600 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
18 | chr9:12415000-12416200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
19 | chr9:12415600-12417400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr9:12415600-12418800 | Weak transcription | Fetal Kidney | kidney |
21 | chr9:12416200-12417000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
22 | chr9:12416400-12417600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
23 | chr9:12416800-12418200 | Enhancers | Brain Germinal Matrix | brain |
24 | chr9:12416800-12418200 | Enhancers | Fetal Brain Male | brain |
25 | chr9:12417400-12417600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |